Association between smoking cessation and short-term health-care use: results from an international prospective cohort study (ATTEMPT) by Beard, E et al.
Association between smoking cessation and
short-term health-care use: results from an
international prospective cohort study (ATTEMPT)
Emma Beard1, Lion Shahab1, Susan J. Curry2 & Robert West1
Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London, UK1 and
Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, IA, USA2
ABSTRACT
Background and aims Previous studies have found that smoking cessation is associated with a short-term increase in
health-care use. This may be because ‘sicker’ smokers are more likely to stop smoking. The current study assessed the
association between smoking cessation and health-care use, adjusting for pre-cessation physical and mental health
conditions. Design/setting Data came from the ATTEMPT cohort, a multi-national prospective survey of smokers in
the United States, Canada, United Kingdom, France and Spain, that lasted 18 months (with follow-ups every 3
months). Participants A total of 3645 smokers completed the baseline questionnaire. All participants smoked at least
five cigarettes per day, intended to quit smoking within the next 3 months and were between 35 and 65 years of age.
Measurements Participants were asked questions about their socio-demographic and smoking characteristics, as well
previous smoking-related morbidities. Participants were also asked to report their health-care use in the previous 3
months i.e. emergency room (ER) visits, hospitalization, whether hospitalization required surgery, and health-care
appointments. Findings A total of 8252, 4779 and 1954 baseline episodes of smoking were available for 3, 6 and
12 months, respectively. Of these, 2.8% (n = 230), 0.9% (n = 40) and 0.7% (n = 14) were followed by 3, 6 and 12 months
of abstinence. No significant differences were found among 3, 6 or 12 months of abstinence and ER visits, hospitali-
zation and whether hospitalization required surgery or health-care visits. However, 6-month smoking cessation epi-
sodes were associated with higher odds of reporting an appointment with a dietician. Conclusion Smoking cessation
does not appear to be associated with a substantial short-term increase or decrease in health-care use after adjusting
for pre-cessation morbidities.
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INTRODUCTION
Clear health benefits accrue from quitting smoking.
Smoking cessation lowers the risk of cancer, coronary
heart disease, aortic aneurysm, stroke, peripheral vas-
cular disease, chronic obstructive pulmonary disease
(COPD) and mortality; it also leads to improved lung
function and reduces the incidence of infertility [1].
These health benefits are translated into long-term
cost savings for health-care services [2,3]. In the United
States smoking-related morbidities account for 6–8%
of national health-care spending [4], while in 2005–
06 smoking-related conditions were estimated to have
cost the National Health Service in England £5.2
billion [5].
Despite smoking cessation reducing use of health-care
services in the long term, several studies have found an
increase in use and health-care costs around the time of
cessation [6–11]. This may be because many smokers
stop once they have become ill [12–14] but it is also
possible that the immediate aftermath of quitting leads to
an increase in health-care service use.
Quitting smoking might motivate smokers to adopt
healthier life-styles, which may include seeking health-
care advice. Alternatively, nicotine withdrawal symp-
toms, including weight gain and flu and cold-like
[The copyright line for this article was changed on 15 July 2014 after original online publication.]
RESEARCH REPORT
bs_bs_banner
doi:10.1111/add.12281
© 2013 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. Addiction, 108, 1979–1988
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
symptoms in the initial weeks following abstinence,
may motivate help-seeking behaviour [15,16]. Thirdly,
ex-smokers may be inclined to visit health-care pro-
fessionals in order to reduce the risk of relapse, i.e. for
further behavioural and/or medicinal support. Fourthly,
it is possible that stopping smoking results in some kind
of physiological disturbance which precipitates an illness
episode. Finally, smokers who are in the early stages of an
illness episode may be motivated to quit smoking and the
natural history of the episode causes help-seeking once
cessation has occurred.
Baumeister et al. [17] recently assessed the hypo-
thesis that the association between smoking cessation
and health-care use was due to sicker smokers attempting
to quit, rather than smoking cessation precipitating
health-care use. Baumeister et al. [17] used retrospective
self-reported data from a sample of more than 4000
adults from Germany. After adjusting for health-care
status and socio-economic variables, no association
was found between time since smoking cessation and
risk of hospitalization. However, the study used a
retrospective cross-sectional design which may be
subject to recall bias. In a recent prospective study of
health-care use and costs among primary care patients
receiving evidence-based smoking cessation treatment,
Hockenberry et al. [8] concluded that smoking cessation
therapy does not raise short-term health-care costs, and
by the sixth quarter, post-quit sustained quitters were sig-
nificantly less expensive than continuing smokers.
If quitting precipitates illness that requires health
service care due to the psychological or physical effects of
the cessation process, any cost–benefit analysis would
need to take these additional costs into account. Addi-
tional prospective studies of the association between
smoking cessation and short-term health-care use
are therefore needed, adjusting for a range of socio-
demographic and smoking characteristics, as well as psy-
chological and physical morbidities. The current study,
using data from the ATTEMPT cohort, aimed to explore
the association prospectively between smoking cessation
and a full range of health services, including emergency
room (ER) visits, hospitalization and health-care appoint-
ments, and to assess the reasons for using these services.
METHODS
Data for this study come from the ATTEMPT cohort, a
multi-national prospective study of smokers which col-
lects data on smoking and socio-demographic character-
istics, as well as physical and mental health outcomes.
Participants were recruited by Harris Interactive, Inc.,
which maintains a market research panel of several
million panellists in more than 125 countries. Each panel
member volunteers to complete regular online surveys
for research purposes in exchange for points that can be
redeemed against merchandise. Full details of the study
methodology are provided elsewhere [18]. Only those
panellists who smoked at least five cigarettes per day,
intended to quit within the following 3 months and were
aged between 35 and 65 years were included into the
current study. The sample was restricted to those who
expressed a desire to quit so that the chances of obtain-
ing an adequate number of quit attempts during the
follow-up period was maximized. Both light and
moderate-to-heavy smokers were included so that the
broad range of smoking habits were captured; the age
range of 35–65 was chosen so that the sample included
people who were likely to be beginning to experience
health problems associated with smoking but before
there would be substantial confounding due to loss of
smokers because of mortality. Panellists were restricted
to United States, Canada, the United Kingdom, France
and Spain (phase 2 of data collection). A total of 3645
panellists were eligible to participate. Participants
completed self-report questionnaires at baseline and
follow-up (i.e. 3, 6, 9, 12, 15 and 18 months).
MEASURES
Demographic characteristics and pre-morbidity
Gender, age, employment status, marital status, body
mass index (BMI), Fagerström Test of Nicotine Depend-
ence (FTND), ethnicity and country were assessed at
baseline and at subsequent follow-up surveys. Diagnosis
of previous smoking related-morbidity was also assessed.
Smokers were asked ‘Have you ever been told by a doctor
or other health care professional that you had any of the
following conditions?’ (heart or circulation condition;
respiratory condition; endocrine, hormone or metabolic
condition; digestive condition; nervous system condition;
cancer; ear, nose or throat condition; bone, joint or
muscle condition; skin condition; reproductive or urinary
condition; other condition).
Smoking status
At each follow-up point smokers were asked: ‘Are you
currently a cigarette smoker?’ (yes, no) and ‘How many
days has it been since you last smoked?’. Those who
reported that they had quit smoking and had not smoked
in the previous 90 days were classified as being abstinent
for 3 months, while those who reported that they had not
quit smoking and had smoked in the previous 90 days
were classified as continuing smokers. Those who were
abstinent for more than 7 days, but fewer than 3 months,
and those who had been abstinent for more than 3
months, were excluded from the analysis. [Note that the
percentage of participants classified as having made a
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3-month quit episode should not be interpreted as a
relapse rate at 3 months, as the comparison is between
continuing smokers as opposed to those who attempted to
quit and failed, i.e. were abstinent for fewer than 3
months].
These classifications were corroborated by asking
smokers three further questions: (i) ‘Just to confirm,
in the last 3 months (90 days) have you smoked any
cigarettes (even a puff ) (yes, no); (ii) Have you smoked
any cigarettes today (yes, no); and (iii) During the past
3 months (90 days), what is the longest period of time
you stopped smoking cigarettes because you were trying
to quit smoking for good?’. Those classified as being absti-
nent for 3 months were re-classified if they reported
having smoked ‘cigarettes today’ and that their longest
period of abstinence was less than 3 months. However, in
all cases a 7-day leeway was given for classification, i.e.
3-month quitters had to be abstinent on the day of testing
and to have quit for between 83 and 90 days. This 7-day
leeway ensured that those who had quit smoking for close
to 3 months were not excluded from the analysis.
Similar categorizations were used for smokers who
had been abstinent for 6 months and 12 months. For
example, those who reported that they had quit smoking
and had not smoked in the previous 180 days were clas-
sified as being abstinent for 6 months, while those who
reported that they had quit smoking and had not smoked
in the previous 360 days were classified as being absti-
nent for 12 months. Each participant could contri-
bute multiple ‘abstinent’ or ‘smoking’ episodes during the
18-month period.
Health-care use
Finally, participants were asked about their health-care
use. This focused on three main areas: (i) visits to ER; (ii)
hospitalization and (iii) health-care appointments.
Visits to ER
Participants were asked: ‘During the past 3 months (90
days), how many times have you gone to a hospital emer-
gency room about your own health’ and ‘What was the
primary reason for your visit to the emergency room
(ER)?’ (heart or circulation condition; respiratory condi-
tion; endocrine, hormone or metabolic condition; diges-
tive condition; nervous system condition; cancer; ear,
nose or throat condition; bone, joint or muscle condition;
other condition). ER refers to emergency departments,
casualty departments and accident and emergency.
Hospitalization
Participants were asked: ‘During the past 3 months (90
days), how many times have you been hospitalized’ and
‘What was the primary reason (e.g. medical condition)
for your hospitalization?’ (heart or circulation condition;
respiratory condition; endocrine, hormone or metabolic
condition; digestive condition; nervous system condition;
cancer; bone, joint or muscle condition; other condition).
Participants were also asked: ‘During which hospitaliza-
tion, if any, did you have any surgery performed?’
Health-care appointments
Participants were asked: ‘Please select each health care
service for which you have had any appointments in the
past 3 months (90 days)’ [out-patient surgery; out-
patient diagnostic procedure (for example, computerized
tomography scan, magnetic resonance imaging, bio-
psy, endoscopy and colonoscopy); laboratory test (for
example, blood or urine test); treatment administra-
tion (for example, dialysis, blood transfusion, radiation,
chemotherapy, injection, infusion); general practitioner
(also includes family physician, internist and primary
care physician consultation); specialist smoking cessa-
tion consultation; other specialist physician consultation
(for example, cardiologist, pulmonologist or gynaeco-
logist); psychological/mental health counselling; nurse
consultation; dietician consultation; physical therapy;
chiropractor visit; acupressure/acupuncture; homeopa-
thy; other health-care service provider].
ANALYSIS
Data were analysed using SPSS version 20.0 (IBM, New
York, NY, USA). In unadjusted analyses, between-group
differences [(i) those followed-up versus those not
followed-up at 3 months (6 and 12 months) and (ii) those
who were abstinent at the 3-month (6-month and
12-month) follow-up versus continuing smokers] were
assessed with χ2 test and t-test analyses for categorical
and continuous variables, respectively. As smokers could
contribute multiple episodes for the analysis between
abstinence and health-care use, generalized estimat-
ing equations (GEE) were used. GEE is a method for
handing correlated discrete data that would typically
be analysed using traditional generalized linear models
(GLM). The primary difference from traditional GLM is its
ability to account for the within-subject covariance struc-
ture for the response data. The fitted model is specified
through a link function (which relates the mean response
to the regression equation), an assumed distribution for
the response (e.g. binomial or Poisson) and a working
correlation matrix. Common link functions are the logit
function g(x) = log[x(1–x)] for binary responses and the
log function g(x) = log(x) for Poisson counts. There are
a number of options for the type of correlation between
observations, e.g. (i) exchangeable: which should be
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adopted when any two observations within a cluster are
equally correlated but there are no correlations between
observations from different clusters; (ii) autoregressive:
should be used when repeated measures are correlated
most strongly when close together in time and correlated
least when furthest apart in time; and (iii) unstructured:
places no constraints on correlations.
In the current study, GEE analyses were based on the
logit link function and used an exchangeable correla-
tion matrix to model the interdependence between data
resulting from some participants reporting multiple absti-
nence and/or continuous smoking episodes. Analyses
adjusted for age, gender, employment status, marital
status, ethnicity, BMI, FTND and smoking-related mor-
bidity. In order to control for unidentified country specific
confounders, a categorical variable specifying each
individual country was also included in the analyses.
Sensitivity analyses were conducted by assessing the
association between health-care use and abstinence
during each follow-up period using multiple-logistic
regression. GEEs were also used to assess whether differ-
ences existed between 3- and 6-month abstinence epi-
sodes and smoking continuation episodes in terms of
the type of health-care appointment that was attended
and whether hospitalization required surgery; 95%
confidence intervals (CI) are given unless stated other-
wise. Where complete separation was evident, i.e. the
presence of one or more covariates perfectly predicted
the outcome of interest, the variables were deleted from
the adjusted analysis. If complete separation was due
to the main predictor variable (i.e. smoking status:
abstinence versus smoking continuation) the analysis
was terminated. Differences were not assessed between
the reasons for ER visits and hospitalization due to
the small sample size; instead descriptive statistics
are presented.
RESULTS
Participants
A total of 68.2% (n = 2485) smokers completed the
3-month follow-up questionnaire, 59.7% (n = 2175)
completed the 6-month follow-up questionnaire, 54.2%
(n = 1975) completed the 9-month follow-up question-
naire, 45.0% (n = 1640) the 12-month follow-up ques-
tionnaire, 33.8% (n = 1233) the 15-month follow-up
questionnaire and 31.8% (n = 1160) the 18-month
follow-up questionnaire (see Supporting information and
Supplementary Table S1 for comparisons between those
followed and not followed-up).
Of those followed-up at 3 months, 8.3% (CI = 7.2–
9.4) reported that they were abstinent for 3 months at
least once during the 18-month period of follow-up,
while 1.8% (CI = 1.4–2.5) of those followed-up at 6
months reported that they were abstinent for 6 months
during the study period. Finally, 0.9% (CI = 0.5–1.4) of
those followed-up at 12 months reported that they were
abstinent for at least 12 months. Among those reporting
abstinence for 3 months, 88.3% (n = 181; CI = 83.2–
92.0) had been abstinent only once during the 18-month
period, 11.2% (n = 23; CI 7.6–16.3) twice, and 0.5%
(n = 1; CI = 0.1–2.7) three times. In contrast, smokers
who were abstinent for 6 or 12 months reported just one
episode of abstinence. Those who had been abstinent at
least once for 3 months differed from those who had not
been abstinent for 3 months; they were more likely to
have been diagnosed with an endocrine, hormone or
metabolic disorder (χ2 = 3.83, d.f. 1, P = 0.050), on
average had a significantly lower FTND score (t = 4.22,
d.f. 2434, P < 0.001) and higher body mass index
(t = −2.65, d.f. 2483, P = 0.008). Those who had been
abstinent for 6 and 12 months did not differ from
those who had not been abstinent for 6 or 12 months
(see Table 1).
Smoking episodes
For the analysis of 3-month abstinence, participants
contributed 10 668 episodes of a possible 21 870 (if all
had completed each follow-up point). Around 2500
episodes were excluded from the analysis of 3-month
quit attempts, as they involved either an attempt to stop
smoking in the previous 3 months which lasted between
8 and 82 days or an episode of abstinence which had
lasted more than 3 months. This resulted in a final sample
of 8252 episodes, of which 230 (2.8%) were classified as
3-month quit attempts and 8022 (97.2%) as smoking
continuation. For the analysis of 6-month abstinence,
participants contributed 8183 episodes of a possible
18 225 episodes. A further 4729 episodes were excluded
from the 6-month analysis, as they involved either an
attempt to stop smoking in the previous 6 months which
lasted between 8 and 172 days or an episode of absti-
nence which had lasted more than 6 months. This
resulted in a final sample of 4779 episodes, of which
40 (0.9%) were classified as a 6-month quit attempt
while 4738 (99.1%) as smoking continuation. Finally,
for the analysis of 12 months abstinence, partici-
pants contributed 4033 episodes of a possible 10 935
episodes, of which 2079 were excluded as they involved
either an attempt to stop smoking in the previous
12 months which lasted between 8 and 357 days or an
episode of abstinence which had lasted more than
12 months. This resulted in a final sample of 1954
episodes. Fourteen of these (0.7%) were classified as a
12-month quit attempt and 1940 (99.3%) as smoking
continuation.
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Association with health-care use
Table 2 shows the percentage of episodes which involved
at least one ER visit, at least one hospitalization and at
least one health-care appointment in the 3 months fol-
lowing smoking cessation, as a function of the cohorts
of interest. ER visits and hospitalization were mainly for
‘heart or circulation conditions’ and ‘other conditions’.
Seeking help for bone, joint and muscle conditions was
also common among smoking continuation episodes.
The most common health-service appointments were for
general practitioners and laboratory tests. Table 3 shows
the results of the GEE analyses of these data. No signifi-
cant differences in terms of ER visits, hospitalization or
health-care visits were found between episodes involving
abstinence (for either 3, 6 or 12 months) and episodes
involving continued smoking. This was corroborated in
the sensitivity analysis. There was only one significant
difference in terms of the type of appointment attended:
6-month abstinence episodes were significantly more
likely to be followed by a visit to a dietician compared to
appointment visits during continuing smoking episodes
[odds ratio (OR) = 8.18, CI = 2.00–33.55, P < 0.01]. No
difference was found in terms of whether or not surgery
was necessary during hospitalization.
DISCUSSION
This study investigated the relationship between smoking
cessation and health-care use in the following months.
No association was found between smoking cessation
and subsequent ER visits, hospitalization or health-care
service appointments. There was also no difference in
terms of whether or not hospitalization required surgery;
however 6-month smoking cessation episodes were
associated with higher odds of reporting an appointment
with a dietician.
In line with previous studies [11,17], our findings
suggest that there is no initial increase in health-care
use within 3 months following smoking cessation, as
measured by ER visits, hospitalization and appoint-
ments with health-care services. Our study was also well
powered to detect medium-sized changes in health-care
use at 6 months, but clearly underpowered to draw firm
conclusions about health-care use within 12 months.
Meta-analyses are required which combine the longer-
term data reported here with data from other studies,
in order to determine the effects of long-term smoking
cessation on hospital visits and other health-care use.
To our knowledge, this is the first prospective study
to assess the association between smoking cessation and
various health-care services which has also adjusted for
multiple socio-demographic and smoking characteristics,
as well as psychological and physical health complaints—
all of which are important determinants of health-care
use [19–22]. We also adjusted for participants’ country of
residence, as differences in country health-care structure
may impact upon use of services following abstinence,
e.g. there are significant differences in the privatization of
health-care in the United States and United Kingdom
which could result in lower use. Unlike previous studies,
the current study used a multi-country design and
assessed the association between cessation and multiple
health complaints and types of health-care services.
It appeared that recent ex-smokers did not seek help
for conditions different from continuing smokers in the
short term. The most common complaints involved ‘heart
or circulation conditions’ and ‘other conditions’, e.g.
trauma. However, those continuing to smoke appeared
to be more likely to seek help for bone, joint or muscle
conditions. Although strong conclusions cannot be
drawn due to the small sample size, this could reflect
improvements in circulation and inflammation following
smoking cessation [1]. This is a particularly novel finding
and provides further support for the argument that,
relative to continuing smokers, recent ex-smokers do
not burden our health-care services. Their higher rate
of dietician appointments at 6 months, relative to other
types of appointments, could be due to recent ex-smokers
attempting to adopt healthier life-styles generally and/or
due to the weight gain which usually occurs following
smoking cessation [16].
These findings have implications for cost–benefit
analyses in that that there is no reason to include addi-
tional costs associated with smoking cessation as a
consequence of increased health-care use. Smoking
cessation is clearly beneficial in reducing the risk of mor-
bidity and mortality, and consequently in reducing the
economic burden on our health-care services in the long
term [2,3]. If smoking were to be eradicated this would
save the National Health Service (NHS) in England £5.2
billion [4], with even larger health-care savings in other
countries [5]. Although there are currently significant
competing demands for scarce health-care resources
[23], emphasis upon and funding of evidence-based
tobacco control interventions and policies is not under-
mined by any evidence for short-term health-care cost
increases following cessation. In fact, smoking cessation
interventions are among the most cost-effective ways
of improving public health, and have been described
as the gold standard to which other health promotion
programmes should be compared [24].
This study has a number of advantages over previous
studies: its ability to control for multiple confounding
variables; its use of multiple health-care outcomes; and
the use of cross-country data. The study also has a
number of limitations. First, as data were collected online
all measures involved self-report, although self-reported
1984 Emma Beard et al.
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data have been shown to be valid indicators of smoking
status [25]. Secondly, due to the sample size we were
unable to determine whether or not differences existed
in the types of conditions for which individuals sought
help. This would be a useful inclusion in future studies
if enough smokers could be recruited. Thirdly, a number
of smokers were lost to follow-up. This potential loss to
follow-up was anticipated in the study design, with 2000
smokers recruited on the basis of a 50% dropout in
order to attain adequate power. Differences between those
followed-up and not followed-up were small, and previous
studies have shown that the ATTEMPT cohort have char-
acteristics similar to those found in national surveys of
smokers [18]. Finally, the medical conditions adjusted
for in the current study were not exhaustive of all those
that might be affected by smoking cessation. There are
also issues with some of the classification systems; for
example, ‘nervous system condition’ includes illnesses
which vary to differing extents in their biological and
psychological underpinnings.
CONCLUSION
In a multi-national cohort of smokers, the current study
found no substantial short-term change in health-care
use, as measured by ER visits, hospitalization and
appointments, when smokers stop.
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